UP Strategic Wealth Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
1,330
+59
+5% +$59.8K 0.82% 21
2025
Q4
$1.34M Buy
1,271
+2
+0.2% +$1.91K 0.98% 17
2025
Q3
$1.05M Buy
1,269
+46
+4% +$34.2K 0.79% 25
2025
Q2
$953K Buy
1,223
+20
+2% +$15.5K 0.74% 25
2025
Q1
$994K Buy
1,203
+482
+67% +$401K 0.88% 21
2024
Q4
$557K Sell
721
-197
-21% -$163K 0.56% 32
2024
Q3
$813K Buy
918
+197
+27% +$177K 0.91% 22
2024
Q2
$653K Hold
721
0.99% 23
2024
Q1
$561K Buy
721
+52
+8% +$37K 0.92% 24
2023
Q4
$390K Buy
+669
New +$390K 0.71% 35

Other funds holding LLY

UP Strategic Wealth Investment Advisors's LLY Position: Q1 2026 in Review

UP Strategic Wealth Investment Advisors increased its Eli Lilly (LLY) stake by 4.6% in Q1 2026, buying an estimated $59.8K and bringing the position to 1,330 shares worth $1.3M. The position accounts for 0.82% of the portfolio, ranked #21.

UP Strategic Wealth Investment Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.34M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • UP Strategic Wealth Investment Advisors held 1,330 shares of Eli Lilly worth $1.3M as of Q1 2026.
  • UP Strategic Wealth Investment Advisors bought 59 Eli Lilly shares in Q1 2026, an estimated $59.8K.
  • Eli Lilly made up 0.82% of UP Strategic Wealth Investment Advisors's portfolio in Q1 2026, its #21 holding.
  • UP Strategic Wealth Investment Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • UP Strategic Wealth Investment Advisors's Eli Lilly position peaked at $1.34M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on UP Strategic Wealth Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.